Medicare Enrolled
Dr. Shemin Gupta, MD
Hematology · Lake Mary, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gupta from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gupta? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Gupta
Dr. Shemin Gupta is a hematology in Lake Mary, FL, with 17 years in practice. Based on federal Medicare data, Dr. Gupta performed 175,333 Medicare services across 4,468 unique beneficiaries.
Between the years covered by Open Payments, Dr. Gupta received a total of $11,510 from 74 pharmaceutical and/or device companies across 639 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Gupta is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice▲ Top 29% volume in FL$ $11,510 industry payments
Medicare Practice Summary
Medicare Utilization ↗175,333
Medicare services
Top 29% in FL for hematology
4,468
Unique beneficiaries
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~10,314 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 76,500 | $0 | $4 |
| Iron sucrose injection (Venofer) | 29,200 | $0 | $5 |
| Filgrastim injection (Zarxio) for white blood cells | 13,800 | $0 | $2 |
| Anti-nausea injection (aprepitant) | 12,610 | $1 | $5 |
| Pembrolizumab injection (Keytruda) | 11,200 | $43 | $137 |
| Epoetin alfa injection (Procrit) for anemia | 8,080 | $6 | $23 |
| Denosumab injection (Prolia/Xgeva) | 6,300 | $18 | $51 |
| Dexamethasone injection (steroid) | 2,600 | $0 | $3 |
| Complete blood count (CBC) with differential | 2,563 | $8 | $29 |
| Blood draw (venipuncture) | 2,347 | $8 | $9 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,590 | $1 | $28 |
| Office visit, established patient (30-39 min) | 1,394 | $94 | $339 |
| Drug injection, under skin or into muscle | 1,333 | $10 | $69 |
| Anti-nausea injection (ondansetron/Zofran) | 928 | $0 | $9 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 813 | $1 | $6 |
| Injection of additional new drug or substance into vein | 415 | $11 | $61 |
| Administration of chemotherapy into vein, 1 hour or less | 408 | $95 | $378 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 404 | $47 | $189 |
| Injection, carboplatin, 50 mg | 304 | $2 | $41 |
| Injection, zoledronic acid, 1 mg | 282 | $7 | $69 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 281 | $22 | $84 |
| Office visit, established patient (20-29 min) | 201 | $59 | $239 |
| Injection of drug or substance into vein | 190 | $28 | $156 |
| Office visit, established patient, complex (40-54 min) | 167 | $137 | $474 |
| Administration of chemotherapy into vein, each additional hour | 142 | $21 | $79 |
| Administration of additional new drug or substance into vein, 1 hour or less | 122 | $47 | $178 |
| Injection, diphenhydramine hcl, up to 50 mg | 116 | $1 | $3 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 108 | $55 | $206 |
| Infusion into a vein for hydration, each additional hour | 104 | $10 | $42 |
| New patient office visit (45-59 min) | 102 | $122 | $453 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 95 | $17 | $59 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 87 | $1 | $7 |
| Infusion into a vein for hydration, 31-60 minutes | 81 | $24 | $156 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 68 | $15 | $56 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 67 | $3 | $11 |
| Infusion, normal saline solution , 1000 cc | 65 | $2 | $7 |
| Administration of additional new drug or substance into vein using push technique | 56 | $35 | $170 |
| Prothrombin time test (blood clotting) | 54 | $4 | $15 |
| Automated urinalysis | 47 | $2 | $8 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 45 | $13 | $56 |
| New patient office visit, complex (60-74 min) | 37 | $173 | $585 |
| Red blood count, automated test | 27 | $4 | $10 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
44.3% high complexity
51.6% medium
4.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$11,510
Total received (2018-2024)
Avg $1,644/year across 7 years
Top 39% in FL for hematology
74
Companies
639
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,335 (98.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$175 (1.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$2,396
2023$2,598
2022$2,221
2021$864
2020$917
2019$1,349
2018$1,165
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$1,402
Janssen Biotech, Inc.
$841
Celgene Corporation
$830
PFIZER INC.
$645
Incyte Corporation
$554
E.R. Squibb & Sons, L.L.C.
$524
Merck Sharp & Dohme Corporation
$452
Genentech USA, Inc.
$420
Merck Sharp & Dohme LLC
$398
GENZYME CORPORATION
$357
Daiichi Sankyo Inc.
$352
Amgen Inc.
$340
Seagen Inc.
$333
ABBVIE INC.
$298
Gilead Sciences, Inc.
$266
Lilly USA, LLC
$245
GlaxoSmithKline, LLC.
$242
Astellas Pharma US Inc
$230
AstraZeneca Pharmaceuticals LP
$200
Kite Pharma, Inc.
$200
Boehringer Ingelheim Pharmaceuticals, Inc.
$168
Bayer HealthCare Pharmaceuticals Inc.
$165
BeiGene USA, Inc.
$140
Eisai Inc.
$126
Octapharma USA, Inc.
$88
Karyopharm Therapeutics Inc.
$75
Pharmacyclics LLC, An AbbVie Company
$74
Takeda Pharmaceuticals U.S.A., Inc.
$72
Ipsen Biopharmaceuticals, Inc
$70
Bayer Healthcare Pharmaceuticals Inc.
$65
Stemline Therapeutics Inc.
$64
Regeneron Healthcare Solutions, Inc.
$64
TerSera Therapeutics LLC
$62
TAIHO ONCOLOGY, INC.
$62
EISAI INC.
$61
MEDIVATION FIELD SOLUTIONS LLC
$51
ARRAY BIOPHARMA INC
$51
EMD Serono, Inc.
$50
Rigel Pharmaceuticals, Inc.
$50
JAZZ PHARMACEUTICALS INC.
$49
Taiho Oncology, Inc.
$48
Pharmacyclics LLC, an AbbVie Company
$44
CSL Behring
$41
Foundation Medicine, Inc.
$39
Seattle Genetics, Inc.
$38
Blueprint Medicines Corporation
$37
AVEO Pharmaceuticals, Inc.
$37
AMAG Pharmaceuticals, Inc.
$34
Alexion Pharmaceuticals, Inc.
$30
Apellis Pharmaceuticals, Inc.
$28
NanoString Technologies, Inc.
$24
Myriad Genetic Laboratories, Inc.
$23
Pharmacosmos Therapeutics Inc.
$22
Exelixis Inc.
$22
GE HealthCare
$21
Shire North American Group Inc
$21
Sobi, Inc
$20
SpringWorks Therapeutics, Inc.
$18
TESARO, Inc.
$18
Acceleron Pharma, Inc.
$18
ADC Therapeutics America, Inc.
$18
Spectrum Pharmaceuticals Inc.
$17
EUSA Pharma (US) LLC
$16
ImmunoGen, Inc.
$15
Alnylam Pharmaceuticals Inc.
$15
Aurobindo Pharma USA, Inc.
$15
Global Blood Therapeutics, Inc.
$15
Dova Pharmaceuticals
$14
PUMA BIOTECHNOLOGY, INC.
$14
Adaptive Biotechnologies Corporation
$13
Emmaus Medical, Inc.
$12
Agios Pharmaceuticals, Inc.
$12
AbbVie Inc.
$11
Veracyte, Inc.
$2
Top 3 companies account for 26.7% of total payments
Associated products mentioned in payments ›
ABECMA · ADAKVEO · ADCETRIS · ALIMTA · AYVAKIT · Alecensa · Aliqopa · Avastin · BAVENCIO · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Blincyto · CABLIVI · CALQUENCE · CEREZYME · COSELA · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIQUIS · ELITEK · ELREXFIO · EMEND · EMPLICITI · ENHERTU · EPKINLY · ERBITUX · ERLEADA · Empaveli · Endari · Enhertu · Erleada · FERAHEME · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · Folotyn · GAZYVA · GILOTRIF · GIVLAARI · Gavreto · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Idelvion · Imbruvica · JADENU · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LYNPARZA · Lenvima · Lonsurf · Lunsumio · MEKINIST · MONJUVI · MVASI · MYRISK · NERLYNX · NINLARO · Neulasta · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OGSIVEO · OJJAARA · ONUREG · OPDIVO · OPDUALAG · OXBRYTA · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · PROSIGNA ASSAY · Padcev · Perjeta · Phesgo · Pomalyst · REBLOZYL · RYBREVANT · Reblozyl · Revlimid · Rezlidhia · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SOMATULINE DEPOT · SUTENT · Stivarga · Sylvant · TASIGNA · TAXOTERE · TECVAYLI · TIBSOVO · TUKYSA · Tavalisse · Tecentriq · Trodelvy · ULTOMIRIS · VENCLEXTA · VERZENIO · VPRIV · Vanflyta · Venclexta · Vitrakvi · XALKORI · XGEVA · XOSPATA · XPOVIO · XTANDI · Xofigo · Xospata · Yescarta · ZEJULA · ZEPZELCA · Zevalin · Zoladex · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $7 per 100 Medicare services performed
Geographic Context
Hematologys within 10 mi
18
Per 100K population
3.8
County median income
$83,030
Nearest hospital
CENTRAL FLORIDA LAKE MONROE HOSPITAL
3.7 mi
3.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Gupta is a mixed practice specialist, with above-average Medicare volume (top 29% in FL), and low-engagement industry engagement, with 17 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Gupta experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Gupta performed 76,500 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gupta receive payments from pharmaceutical companies?
Yes. Dr. Gupta received a total of $11,510 from 74 companies across 639 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gupta's costs compare to other hematologys in Lake Mary?
Dr. Gupta's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gupta) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologys in Lake Mary
Browse hematologys in Lake Mary ranked by procedure volume and transparency data.
Highest volume
Top Hematologys in FL
Hematologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologys in FL
Which FL hematologys receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc..
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology